Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pheronym has developed a patented technology using water-soluble pheromones to direct the behavior of microscopic roundworms called nematodes. Their lead products—Nemastim™ and PheroCoat™—are designed to improve crop protection by either enhancing the effectiveness of beneficial nematodes against insect pests or repelling plant-parasitic nematodes from crops. Greenhouse demonstrations are ongoing, with partnerships under negotiation for broader commercialization. The company has received grants including from the NSF and has conducted research with NASA on the International Space Station to further develop their eco-friendly pest control solutions. No clinical results apply as this company operates in agricultural biotechnology rather than human therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pheronym.